Menu
Back to User profile » Dr Zhiqiang Meng
Papers published by Dr Zhiqiang Meng:
Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study
Li H, Qin S, Liu Y, Chen Z, Ren Z, Xiong J, Meng Z, Zhang X, Wang L, Zhang X, Zou J
Drug Design, Development and Therapy 2021, 15:1873-1882
Published Date: 3 May 2021
Overexpression of a Long Non-Coding RNA BC037916 is Associated with Pancreatic Tumorigenesis and Poor Prognosis
Chen G, Xu L, Ye G, Lin J, Meng Z, Shen Y
OncoTargets and Therapy 2020, 13:13451-13463
Published Date: 5 January 2021
miR-939-5p Contributes to the Migration and Invasion of Pancreatic Cancer by Targeting ARHGAP4
Shen Y, Chen G, Gao H, Li Y, Zhuang L, Meng Z, Liu L
OncoTargets and Therapy 2020, 13:389-399
Published Date: 14 January 2020
SLC5A1 promotes growth and proliferation of pancreatic carcinoma via glucose-dependent AMPK/mTOR signaling
Gao HF, Chen LY, Cheng CS, Chen H, Meng ZQ, Chen Z
Cancer Management and Research 2019, 11:3171-3185
Published Date: 12 April 2019
Second primary malignancy in patients with cholangiocarcinoma: a population-based study
Zhuang L, Yan X, Meng Z
Cancer Management and Research 2019, 11:1969-1983
Published Date: 1 March 2019
High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cells
Ning Z, Zhu Z, Wang H, Zhang C, Xu L, Zhuang L, Yan X, Wang D, Wang P, Meng Z
OncoTargets and Therapy 2019, 12:1161-1170
Published Date: 12 February 2019
HIFU is safe, effective, and feasible in pancreatic cancer patients: a monocentric retrospective study among 523 patients
Ning Z, Xie J, Chen Q, Zhang C, Xu L, Song L, Meng Z
OncoTargets and Therapy 2019, 12:1021-1029
Published Date: 1 February 2019
Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma
Zhu Z, Xu L, Zhuang L, Ning Z, Zhang C, Yan X, Lin J, Shen Y, Wang P, Meng Z
OncoTargets and Therapy 2018, 11:6731-6740
Published Date: 10 October 2018
Solute carrier transporters: potential targets for digestive system neoplasms
Xie J, Zhu XY, Liu LM, Meng ZQ
Cancer Management and Research 2018, 10:153-166
Published Date: 24 January 2018
Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma
Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z
OncoTargets and Therapy 2017, 10:1441-1449
Published Date: 6 March 2017
Prognostic nutritional index serves as a predicative marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma
Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z
OncoTargets and Therapy 2016, 9:6417-6423
Published Date: 19 October 2016